Daejeon, South Korea

Ui Jin Lee

This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Haesung Bio Co., Ltd., Nanobiotech Co., Ltd.. Active years: 2016-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ui Jin Lee. Retrieved from https://idiyas.com/inventor/ui-jin-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.5

ph-index = 1


Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ui Jin Lee: Innovator in Microbial Detection and Diabetes Treatment

Introduction

Ui Jin Lee is a noteworthy inventor based in Daejeon, South Korea. He holds two patents that reflect his dedication to advancing scientific research in the fields of microbial detection and diabetes treatment. His innovations demonstrate a blend of scientific rigor and practical application, contributing to important advancements in these areas.

Latest Patents

One of Ui Jin Lee's latest patents focuses on a composition for detecting microbial contamination, which includes a preparation for detecting nucleases. This invention enhances the ability to quickly and accurately detect live microorganisms in various samples. Utilizing a probe that measures nucleic acid double-stranded nucleases, this composition features a fluorescence signal that increases consistently. This characteristic allows for reliable quantification of microorganisms, making it an excellent tool for environmental monitoring.

His second patent involves a compound isolated from quamoclit, which is formulated into a composition for preventing or treating diabetes and its related complications. This novel compound exhibits significant effects such as lowering blood sugar and promoting insulin secretion, while also inhibiting the expression of VEGF. Importantly, it has the potential to enhance the effectiveness of traditional diabetes medications, thus offering a promising avenue for treatment.

Career Highlights

Throughout his career, Ui Jin Lee has contributed significantly to the field of biotechnology. He has been associated with reputable companies such as Haesung Bio Co., Ltd. and Nanobiotech Co., Ltd., where he has applied his expertise in developing groundbreaking solutions in health and life sciences.

Collaborations

Ui Jin Lee has collaborated with esteemed individuals in the industry, including Bong Hyun Chung and So Yeon Yi. These partnerships have likely enriched his work and fostered the generation of innovative ideas and solutions.

Conclusion

In summary, Ui Jin Lee stands out as an influential inventor whose work has the potential to make a lasting impact on microbial detection and diabetes treatment. With his innovative patents and collaborations, he continues to push the boundaries of scientific research, ultimately contributing to advancements that benefit society as a whole.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…